Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wenzhou Kangning Hospital CoFRA:4WK +1.63%75 Return-on-Tangible-Asset is 2.69% as of Jun. 2026, which is 13% below its 10-year median of 3.09. GuruFocus rates FRA:4WK with a GF Score™ of 75/100 and a GF Value™ of €1.35. The stock has 2 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Wenzhou Kangning Hospital Co ranks worse than 52.27% on this metric.
The historical rank and industry rank for Wenzhou Kangning Hospital Co's Return-on-Tangible-Asset or its related term are showing as below:
FRA:4WK'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -1.08 Med: 3.09 Max: 5.17
Current: 2.03
During the past 12 years, Wenzhou Kangning Hospital Co's highest Return-on-Tangible-Asset was 5.17%. The lowest was -1.08%. And the median was 3.09%.
FRA:4WK's Return-on-Tangible-Asset is ranked worse than 52.27% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 2.43
vs FRA:4WK: 2.03
Wenzhou Kangning Hospital Co (FRA:4WK) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Wenzhou Kangning Hospital Co Return-on-Tangible-Asset Related Terms
Wenzhou Kangning Hospital Co Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wenzhou Kangning Hospital Co Return-on-Tangible-Asset Chart
FRA:4WK vs HCA, THC, DVA: Return-on-Tangible-Asset Comparison
For the Medical Care Facilities subindustry, Wenzhou Kangning Hospital Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wenzhou Kangning Hospital Co Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Wenzhou Kangning Hospital Co's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Wenzhou Kangning Hospital Co's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 2.69% mean?
Wenzhou Kangning Hospital Co (FRA:4WK) has a Return-on-Tangible-Asset of 2.69% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Wenzhou Kangning Hospital Co and its competitors. This is 13% below median its historical median of 3.09. According to the industry distribution chart, Wenzhou Kangning Hospital Co ranks #357 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 52.3%.
Is Wenzhou Kangning Hospital Co's Return-on-Tangible-Asset too high?
Wenzhou Kangning Hospital Co's current Return-on-Tangible-Asset of 2.69% is 13% below median its 10-year median of 3.09. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.43. Wenzhou Kangning Hospital Co's value of 2.69% is 10.7% above this industry median. Based on the distribution chart, Wenzhou Kangning Hospital Co ranks #357 out of 683 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Wenzhou Kangning Hospital Co has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Wenzhou Kangning Hospital Co's Return-on-Tangible-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Wenzhou Kangning Hospital Co ranks #357 out of 683 companies for Return-on-Tangible-Asset. This places Wenzhou Kangning Hospital Co in the lower half of its industry. The industry median Return-on-Tangible-Asset is 2.43. Wenzhou Kangning Hospital Co's value of 2.69% is 10.7% above this benchmark. While the company's 10-year median is 3.09 vs. the industry median of 2.43, Wenzhou Kangning Hospital Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.43, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wenzhou Kangning Hospital Co's current Return-on-Tangible-Asset of 2.69% is 10.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Wenzhou Kangning Hospital Co and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wenzhou Kangning Hospital Co's current Return-on-Tangible-Asset is 2.69%, which is 13% below median its own 10-year median of 3.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wenzhou Kangning Hospital Co stock overvalued right now?
Wenzhou Kangning Hospital Co (FRA:4WK) has a current Return-on-Tangible-Asset of 2.69%. The stock's GF Value™ is €1.35, compared to a current price of €0.94 — trading 30.7% below its estimated fair value. The current Return-on-Tangible-Asset is 2.69%, which is 13% below median its 10-year median of 3.09 and 10.7% above the Healthcare Providers & Services industry median of 2.43. Wenzhou Kangning Hospital Co's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Wenzhou Kangning Hospital Co (FRA:4WK), the current Return-on-Tangible-Asset is 2.69% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wenzhou Kangning Hospital Co (FRA:4WK) Overvalued in 2026?
Based on GuruFocus' analysis, Wenzhou Kangning Hospital Co stock appears to be undervalued.
The current stock price of €0.94 is trading 30.7% below its estimated GF Value™ of €1.35.
Key valuation signals for FRA:4WK:
Return-on-Tangible-Asset: 2.69% (13% below median its 10-year median of 3.09)
GF Value™: €1.35 vs. price of €0.94 (30.7% below fair value)
Industry Position: 10.7% above the Healthcare Providers & Services median (#357 of 683)
No single metric tells the full story. See the FRA:4WK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wenzhou Kangning Hospital Co Ltd is engaged in operating a network of healthcare facilities that focus on providing psychiatric specialty care and elderly rehabilitation service across various regions in China. It derives revenue from operating its owned hospitals consists of fees charged for outpatient visits and inpatient services at the group's various hospitals, which can be divided into treatment and general healthcare services and pharmaceutical sales, as well as variable considerations for medical services provided by the group, mainly including medical insurance settlement differences.
75GF Score
Get the complete analysis for FRA:4WK
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4WK has been successfully added to your 
